new cancer drug, Glivec
There's a lot of excitement about the new cancer drug, Glivec.
Novartis is marketing it now in the U.S., but under the brand name Gleevec. The drug company is still deciding whether to call it Gleevec or Glivec when it becomes available in Canada later.
Glivec (imatinib) is effective for treating chronic myeloid leukemia (CML)...plus it might also be useful for treating other forms of cancer.